Milestone Pharmaceuticals Inc. (MIST)
NASDAQ · Manufacturing · Pharmaceutical preparations
$0.8000+$0.0051 (+0.64%) on the dayAs of the close; data may be delayed.
MIST price, last 12 months
Key stats
- Previous close
- $0.7949
- Open
- $0.8200
- Day range
- $0.7521 – $0.8300
- 52-week range
- $0.7521 – $3.06
- Volume
- 1.2M
- Avg volume (20 days)
- 1.5M
- Market cap
- $98.2M
Performance
1W−12.6%
1M−32.2%
3M−35.5%
6M−30.4%
YTD−60.4%
1Y−58.8%
vs S&P 500, 1Y−75.5 pts
Technicals and fundamentals
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $98.2M